CDSN Activators
CDSN activators refer to a category of chemicals that facilitate the activation of the Corneodesmosin (CDSN) protein, which is typically expressed in the granular and cornified layers of the epidermis. CDSN is integral to the structure and function of corneodesmosomes, which are specialized cell structures that contribute to cell adhesion within the epidermis. The precise role of CDSN in these structures is thought to be related to the maintenance of skin integrity and barrier function.
Direct activators of CDSN would interact with the protein in a way that enhances its role in corneodesmosomes. This could involve binding to CDSN and inducing a conformational change that increases its affinity for other proteins within the corneodesmosome complex, or it could stabilize the protein's structure, thereby enhancing its function in cell adhesion processes. The enhanced function of CDSN could lead to a more robust intercellular linkage, contributing to the understanding of epidermal cohesion and barrier function. Indirect activators, on the other hand, might upregulate the expression of the CDSN gene, leading to an increase in protein synthesis. They could also act by inhibiting proteases that degrade CDSN, thus increasing its half-life and functional presence in the skin. Moreover, indirect activators could promote the assembly of corneodesmosomes by facilitating the interaction between CDSN and its binding partners, thereby reinforcing cellular adhesion.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases cyclic AMP (cAMP) levels, activating the protein kinase A (PKA) pathway. PKA can phosphorylate and activate various proteins, including CDSN, by altering their conformation and function. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid binds to the retinoic acid receptor (RAR), leading to downstream activation of the JAK/STAT pathway. STAT proteins can interact with and modulate the function of CDSN. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK-3β, impacting the Wnt/beta-catenin signaling. Beta-catenin, when stabilized, can interact with CDSN and alter its function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the JNK pathway and p38 MAPK, both involved in stress responses. These pathways can phosphorylate and activate CDSN. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a corticosteroid, modulates the glucocorticoid receptor pathway, which can regulate the transcription of CDSN and influence its expression. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Capsaicin activates the TRPV1 ion channel, leading to increased calcium influx and activation of calcineurin. Calcineurin can dephosphorylate CDSN and modulate its function. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin. Despite being a dephosphorylating agent, calcineurin can alter the function of CDSN in certain contexts. Cyclosporin A, thus, indirectly affects CDSN. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Tacrolimus, like Cyclosporin A, inhibits calcineurin, indirectly modulating CDSN function. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 triggers the prostaglandin signaling pathway, which can influence the expression and function of CDSN. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $374.00 | 4 | |
Leukotriene B4 activates the LTB4 receptor and downstream signaling, which can modulate the function of CDSN. | ||||||